Relationship between Regional Cerebral Blood Flow in 99m-Tc-ECD SPECT and Symptom Profiles in Unmedicated Patients with Schizophrenia.
- Author:
Suk Kyoon AN
1
;
Duk In JON
;
Jong Doo LEE
;
Sung Kil MIN
Author Information
1. Department of Psychiatry, College of Medicine, Yonsei University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Schizophrenia;
Positive symptom;
Negative symptom;
Regional cerebral blood flow;
single-photon emission computed topography
- MeSH:
Basal Ganglia;
Frontal Lobe;
Ganglia;
Humans;
Perfusion;
Schizophrenia*;
Temporal Lobe;
Thalamus;
Tomography, Emission-Computed, Single-Photon*
- From:Journal of Korean Neuropsychiatric Association
1997;36(3):433-443
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Symptom profiles in schizophrenia consists of positive and negative symptom dimensions which are considered to be related to different underlying pathophysiologies and neural substrates. The purpose of the study was to identify the possible relationship between relative regional cerebral perfusion and positive and negative symptom dimension in unmedicated patients with schizophrenia. Twenty-seven unmedicated patients with schizophrenia(13 patients who were antipsychotic drug-naive and 14 patients who had been drug-free for at least 1 week) were included in the study. Regional cerebral perfusion was studied with the single-photon emission computed tomography(SFECT). Symptom dimensions were assessed with positive and negative syndrome scale(PANSS). The scores of each symptom dimension were correlated with regional cerebral perfusion. The results were 1) positive symptom dimension score was significantly related to decreased perfusion in the medial temporal lobe and increased perfusion in the frontal lobe, 2) negative symptom dimension score was significantly related to decreased perfusion in the basal ganglia, thalamus and increased perfusion in the frontal lobe. These results suggest that positive symptom dimension is associated with the dysfunction of the link between the frontal lobe and the medial temporal lobe and that negative symptom dimension is related with the impairment of frontal-basal ganglia circuit.
